Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
American Society for Clinical Investigation
Online
2020-01-27
DOI
10.1172/jci99934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- P2518Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events
- (2018) M Husain et al. EUROPEAN HEART JOURNAL
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
- (2016) Anders Jorsal et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Antidiabetic Hormone Glucagon-Like Peptide-1 Induces Formation of New Elastic Fibers in Human Cardiac Fibroblasts After Cross-Activation of IGF-IR
- (2015) Nour Qa'aty et al. ENDOCRINOLOGY
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart
- (2015) Karpagam Aravindhan et al. PLoS One
- Suppression of soluble adenylyl cyclase protects smooth muscle cells against oxidative stress-induced apoptosis
- (2014) Sanjeev Kumar et al. APOPTOSIS
- Role of soluble adenylyl cyclase in cell death and growth
- (2014) Yury Ladilov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- New insights concerning the molecular basis for defective glucoregulation in soluble adenylyl cyclase knockout mice
- (2014) George G. Holz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Antiatherothrombotic Effects of Dipeptidyl Peptidase Inhibitors
- (2014) Alison Cameron-Vendrig et al. Current Atherosclerosis Reports
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- p27 Protein Protects Metabolically Stressed Cardiomyocytes from Apoptosis by Promoting Autophagy
- (2014) Xuetao Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery
- (2014) Zhaobin Xu et al. Jove-Journal of Visualized Experiments
- Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection
- (2014) John R. Ussher et al. Molecular Metabolism
- GLP-1(28–36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro
- (2013) Weijuan Shao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- GLP-1-derived nonapeptide GLP-1(28–36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice
- (2013) Wilfred Ip et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy
- (2013) N Fillmore et al. BRITISH JOURNAL OF PHARMACOLOGY
- Oxysterol-induced apoptosis of smooth muscle cells is under the control of a soluble adenylyl cyclase
- (2013) Avinash Appukuttan et al. CARDIOVASCULAR RESEARCH
- CO2/HCO3−- and Calcium-regulated Soluble Adenylyl Cyclase as a Physiological ATP Sensor
- (2013) Jonathan H. Zippin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- Cyclic AMP efflux, via MRPs and A1 adenosine receptors, is critical for bovine sperm capacitation
- (2013) Claudia Osycka-Salut et al. MOLECULAR HUMAN REPRODUCTION
- Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis
- (2013) Adam McCluskey et al. TRAFFIC
- Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus
- (2012) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation
- (2012) Changjun Yang et al. CARDIOVASCULAR RESEARCH
- A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity
- (2012) Mohammad Hossein Noyan-Ashraf et al. CIRCULATION
- Exenatide Reduces Final Infarct Size in Patients With ST-Segment–Elevation Myocardial Infarction and Short-Duration of Ischemia
- (2012) Jacob Lønborg et al. Circulation-Cardiovascular Interventions
- Cardiovascular Biology of the Incretin System
- (2012) John R. Ussher et al. ENDOCRINE REVIEWS
- Type 10 Soluble Adenylyl Cyclase Is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells
- (2012) Jan-Paul Flacke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GLP1-derived nonapeptide GLP1(28–36)amide protects pancreatic β-cells from glucolipotoxicity
- (2012) Zhengu Liu et al. JOURNAL OF ENDOCRINOLOGY
- Targeting fatty acid and carbohydrate oxidation — A novel therapeutic intervention in the ischemic and failing heart
- (2011) Jagdip S. Jaswal et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Type 10 adenylyl cyclase mediates mitochondrial Bax translocation and apoptosis of adult rat cardiomyocytes under simulated ischaemia/reperfusion
- (2011) Avinash Appukuttan et al. CARDIOVASCULAR RESEARCH
- A Pilot Study to Assess Whether Glucagon-Like Peptide-1 Protects the Heart From Ischemic Dysfunction and Attenuates Stunning After Coronary Balloon Occlusion in Humans
- (2011) Philip A. Read et al. Circulation-Cardiovascular Interventions
- GLP-1-derived nonapeptide GLP-1(28–36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes
- (2011) Eva Tomas et al. REGULATORY PEPTIDES
- GLP-1-derived nonapeptide GLP-1(28–36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice
- (2011) Eva Tomas et al. REGULATORY PEPTIDES
- The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
- (2010) Yumei Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
- (2010) Kiwon Ban et al. ENDOCRINOLOGY
- Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling
- (2010) Mirkka Koivusalo et al. JOURNAL OF CELL BIOLOGY
- Growth Differentiation Factor 5 Regulates Cardiac Repair After Myocardial Infarction
- (2010) Syed H.E. Zaidi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- Soluble Adenylyl Cyclase Controls Mitochondria-dependent Apoptosis in Coronary Endothelial Cells
- (2009) Sanjeev Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
- (2009) Leo Timmers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Capturing adenylyl cyclases as potential drug targets
- (2009) Sandra Pierre et al. NATURE REVIEWS DRUG DISCOVERY
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More